Author:
Mirza Myriam,Goerke Lutz,Anderson Anna,Wilsdon Tim
Reference50 articles.
1. Targeting mutations in cancer;Waarts;J Clin Investig,2022
2. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study;Swen;Lancet,2023
3. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives;Zhong;Signal Transduct Target Ther,2021
4. Implementing genome-driven oncology;Hyman;Cell,2017
5. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe;Kerr;Lung Cancer,2021